Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

The argument for the use of mizoribine in renal transplantation: a meta-analysis and systemic review.

Zhang X, Fu S, Han S, Zheng X, Wang L.

Transpl Immunol. 2013 Mar;28(2-3):106-11. doi: 10.1016/j.trim.2012.12.003. Epub 2013 Jan 9. Review.

PMID:
23313278
[PubMed - indexed for MEDLINE]
2.

Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation--a meta-analysis.

Xing S, Yang J, Zhang X, Zhou P.

Clin Biochem. 2014 May;47(7-8):663-9. doi: 10.1016/j.clinbiochem.2014.01.014. Epub 2014 Jan 24.

PMID:
24463228
[PubMed - in process]
3.

Interleukin 2 receptor antagonists for kidney transplant recipients.

Webster AC, Ruster LP, McGee R, Matheson SL, Higgins GY, Willis NS, Chapman JR, Craig JC.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003897. doi: 10.1002/14651858.CD003897.pub3. Review.

PMID:
20091551
[PubMed - indexed for MEDLINE]
4.

Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.

Knight SR, Russell NK, Barcena L, Morris PJ.

Transplantation. 2009 Mar 27;87(6):785-94. doi: 10.1097/TP.0b013e3181952623. Review.

PMID:
19300178
[PubMed - indexed for MEDLINE]
5.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

PMID:
15899149
[PubMed - indexed for MEDLINE]
Free Article
6.

The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.

Yoshimura N, Ushigome H, Matsuyama M, Nobori S, Suzuki T, Sakai K, Okajima H, Okamoto M.

Transplant Proc. 2012 Jan;44(1):140-3. doi: 10.1016/j.transproceed.2011.12.009.

PMID:
22310599
[PubMed - indexed for MEDLINE]
7.

The beneficial effect of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids on CMV infection in renal transplant recipients.

Yoshimura N, Ushigome H, Akioka K, Nobori S, Suzuki T, Sakai K, Okamoto M.

Clin Exp Nephrol. 2013 Feb;17(1):127-33. doi: 10.1007/s10157-012-0669-4. Epub 2012 Aug 2.

PMID:
23011290
[PubMed - indexed for MEDLINE]
8.

Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.

Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003961. Review.

PMID:
16235347
[PubMed - indexed for MEDLINE]
9.

Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.

Triemer HL, Pearson TC, Odom KL, Larsen CP.

Clin Transplant. 2000 Aug;14(4 Pt 2):413-20.

PMID:
10946781
[PubMed - indexed for MEDLINE]
10.

Alemtuzumab induction in renal transplantation: a meta-analysis and systemic review.

Zhang X, Huang H, Han S, Fu S, Wang L.

Transpl Immunol. 2012 Oct;27(2-3):63-8. doi: 10.1016/j.trim.2012.08.006. Epub 2012 Aug 30. Review.

PMID:
22960043
[PubMed - indexed for MEDLINE]
11.

Influence of serum uric acid levels in response to the conversion from mycophenolate mofetil to mizoribine in kidney transplant recipients.

Ding X, Zhu X, Zhang Y, Zhang L, Cheng M, Yu Y, Xu L, Li G.

Transplant Proc. 2013 Jan-Feb;45(1):190-3. doi: 10.1016/j.transproceed.2012.10.030.

PMID:
23375297
[PubMed - indexed for MEDLINE]
12.

Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis.

Knight SR, Morris PJ.

Transplantation. 2010 Jan 15;89(1):1-14. doi: 10.1097/TP.0b013e3181c518cc. Review.

PMID:
20061913
[PubMed - indexed for MEDLINE]
13.

Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.

Mycophenolate Mofetil Acute Renal Rejection Study Group.

Transplantation. 2001 Apr 27;71(8):1091-7.

PMID:
11374408
[PubMed - indexed for MEDLINE]
14.

Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation.

Keown P, Balshaw R, Khorasheh S, Chong M, Marra C, Kalo Z, Korn A.

BioDrugs. 2003;17(4):271-9.

PMID:
12899644
[PubMed - indexed for MEDLINE]
15.

Induction with and without antithymocyte globulin combined with cyclosporine/tacrolimus-based immunosuppression in renal transplantation: a meta-analysis of randomized controlled trials.

Tian JH, Wang X, Yang KH, Liu AP, Luo XF, Zhang J.

Transplant Proc. 2009 Nov;41(9):3671-6. doi: 10.1016/j.transproceed.2009.06.184.

PMID:
19917365
[PubMed - indexed for MEDLINE]
17.

Interleukin 2 receptor antagonists for kidney transplant recipients.

Webster AC, Playford EG, Higgins G, Chapman JR, Craig J.

Cochrane Database Syst Rev. 2004;(1):CD003897. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD003897.

PMID:
14974043
[PubMed - indexed for MEDLINE]
18.

Steroid avoidance or withdrawal for kidney transplant recipients.

Pascual J, Zamora J, Galeano C, Royuela A, Quereda C.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005632. doi: 10.1002/14651858.CD005632.pub2. Review.

PMID:
19160257
[PubMed - indexed for MEDLINE]
19.

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials.

Webster AC, Lee VW, Chapman JR, Craig JC.

Transplantation. 2006 May 15;81(9):1234-48. Review.

PMID:
16699448
[PubMed - indexed for MEDLINE]
20.

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C.

Transplantation. 1997 Jan 15;63(1):39-47. Erratum in: Transplantation 1997 Feb 27;63(4):618.

PMID:
9000658
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk